Pratiksha Chemicals Limited has announced that its Board of Directors will convene on April 6, 2026, to deliberate on significant changes to the company's main business objects. The meeting notification was submitted to BSE Limited on April 1, 2026, in compliance with Regulation 29(1) of the SEBI Listing Regulations.

Meeting Details and Regulatory Compliance

The board meeting is scheduled for Monday, April 6, 2026, with the primary agenda focusing on proposals to expand the company's main object clause. The notification was signed by Sumit Harjibhai Gol, Additional Director (DIN: 11367027), and submitted to BSE where the company trades under scrip code 531257.

Proposed Business Expansion Areas

The company plans to add two significant sub-clauses to its existing main object clause, expanding from the current eleven sub-clauses to thirteen. These additions represent a strategic shift toward agricultural and allied business activities.

Agri-Inputs and Related Products

The first proposed addition focuses on comprehensive agri-input operations:

• Manufacturing, importing, exporting, and dealing in fertilizers
• Micronutrients and pesticides & insecticides
• Veterinary and livestock feeds and feed supplements
• Fish feeds and supplements
• Wholesale and retail operations across all these categories

Agricultural Equipment and Farming Operations

The second proposed sub-clause encompasses equipment and direct farming activities:

Approval Process and Next Steps

The proposed changes will require multiple levels of approval before implementation. The board meeting represents the first step in this process, where directors will formally consider and potentially approve the expansion proposals.

Should the board approve these changes, the company will need to secure regulatory and statutory approvals as required by law. Additionally, shareholder approval will be necessary, likely through a special resolution at an extraordinary general meeting or the next annual general meeting.

Strategic Implications

These proposed changes indicate Pratiksha Chemicals Limited's intention to diversify its business portfolio significantly. The expansion into agri-inputs, agricultural equipment, and direct farming operations represents a comprehensive approach to the agricultural value chain, potentially positioning the company as an integrated agricultural solutions provider.

Pratiksha Chemicals Limited has withdrawn its proposed fully convertible warrants and preferential equity share issue, citing withdrawal of consent by some investors. The Board of Directors made this decision on February 24, 2026, reversing their earlier approval from January 21, 2026.

Withdrawal Details

The company has cancelled the following proposals that were originally approved in the Board meeting held on January 21, 2026:

The withdrawal was necessitated due to some proposed investors withdrawing their consent to subscribe to the issue, prompting the Board to reconsider the entire proposal during their meeting on February 24, 2026.

Subsidiary Acquisition Plans Shelved

Alongside the share issue withdrawal, the Board has also decided not to proceed with acquiring control over two companies that were planned to become subsidiaries:

• Rudra Professional Services Private Limited
• Right Debt Management Services Private Limited

These acquisition plans were part of the company's expansion strategy but have been put on hold in light of the current circumstances.

Company Assurance

Despite the withdrawal of these significant corporate proposals, Pratiksha Chemicals has assured stakeholders that this decision will not adversely affect the company's financial stability, operations, or growth prospects. The company emphasized its commitment to maintaining transparency with all stakeholders regarding this development.

Meeting Timeline

The Board meeting where the withdrawal decision was finalized commenced at 5:00 PM and concluded at 5:20 PM on February 24, 2026. The company has informed BSE Limited about this development under Regulation 30 of SEBI LODR Regulations, ensuring compliance with disclosure requirements.